株探米国株
エドガーで原本を確認する
0001555280false00015552802026-05-212026-05-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 20, 2026
Zoetis Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-35797 46-0696167
(State or other jurisdiction (Commission File (I.R.S. Employer
of incorporation) Number) Identification No.)
10 Sylvan Way
Parsippany
New Jersey
07054
(Address of principal executive offices) (Zip Code)

(973) 822-7000
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐    Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share ZTS New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

                                     Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Item 5.07. Submission of Matters to a Vote of Security Holders.
As discussed under Item 5.02 of this Current Report on Form 8-K, on May 20, 2026, the Company held the Annual Meeting. At the Annual Meeting, the Company’s shareholders voted on five proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 8, 2026 (the “Proxy Statement”). There were 379,034,516 shares of common stock present at the Annual Meeting in person or by proxy, which represented 90.13% of the voting power of the shares of common stock entitled to vote at the Annual Meeting, and which constituted a quorum for the transaction of business. Holders of the Company’s common stock were entitled to one vote for each share held as of the close of business on March 27, 2026 (the “Record Date”).

The shareholders of the Company voted on the following proposals at the Annual Meeting:

1. To elect twelve directors, each to serve for a one-year term until the 2027 Annual Meeting of Shareholders or until each director’s successor has been elected and qualified, or until such director’s earlier death, resignation or removal.
2. A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Proxy Statement.
3. A non-binding advisory vote on the frequency of future advisory votes on the compensation program for the Company’s named executive officers, as disclosed in the Proxy Statement.
4. To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
5. To approve a shareholder proposal to permit shareholder action by written consent.
The voting results for each of these proposals are detailed below.
1. Election of Directors
Nominee Votes For Votes Against Abstentions Broker Non-Votes
Paul M. Bisaro 344,648,102 13,423,613 498,498 20,464,303
Vanessa Broadhurst 347,969,047 9,893,259 707,907 20,464,303
Frank A. D'Amelio 334,228,663 23,843,344 498,206 20,464,303
Gavin D.K. Hattersley 340,392,396 17,679,615 498,202 20,464,303
Sanjay Khosla 341,507,953 16,564,532 497,728 20,464,303
Antoinette R. Leatherberry 354,536,226 3,535,040 498,947 20,464,303
Michael B. McCallister 339,555,621 18,514,932 499,660 20,464,303
Gregory Norden 330,178,693 27,889,986 501,534 20,464,303
Kristin C. Peck 353,091,387 4,991,721 487,105 20,464,303
Willie M. Reed 344,480,091 13,582,521 507,601 20,464,303
Mark Stetter 354,854,878 3,221,395 493,940 20,464,303
Stephanie Tilenius 355,556,444 2,521,991 491,778 20,464,303
Each of the twelve nominees for director was elected to serve for a one-year term until the 2027 Annual Meeting of Shareholders or until each director’s successor has been elected and qualified, or until such director’s earlier death, resignation or removal.
2. Advisory Vote on Executive Compensation
Votes For Votes Against Abstentions Broker Non-Votes
306,328,992 51,638,692 602,529 20,464,303
The shareholders approved, on a non-binding advisory basis, the compensation program for the Company’s named executive officers, as disclosed in the Proxy Statement.



3. Advisory Vote on Frequency of Future Advisory Votes on Executive Compensation
One Year Two Years Three Years Abstentions Broker Non-Votes
353,402,319 427,780 4,211,897 528,217 20,464,303
The shareholders approved, on a non-binding advisory basis, to hold a non-binding advisory vote on the compensation program for the Company’s named executive officers every year.
Consistent with the preferences expressed by the Company’s shareholders at the Annual Meeting and the recommendation of the Company’s Board of Directors, the Company will continue to hold a non-binding advisory vote on the compensation program for the Company’s named executive officers every year.
4. Ratification of Appointment of Independent Registered Public Accounting Firm
Votes For Votes Against Abstentions Broker Non-Votes
367,031,759 11,450,123 552,634 0
The shareholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
5. Shareholder Proposal
Votes For
Votes Against
Abstentions
Broker Non-Votes
167,308,882 190,220,865 1,040,466 20,464,303
The shareholders did not approve the shareholder proposal to permit shareholder action by written consent.





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ZOETIS INC.
Dated: May 21, 2026 By: /s/ Roxanne Lagano
Roxanne Lagano
Executive Vice President,
General Counsel and Corporate Secretary